Arrhythmias & electrophysiology

His-bundle pacing and atrioventricular nodal ablation for noncontrolled atrial arrhythmia: A technical challenge with major clinical benefits

Heart RhythmPublished Prospective cohort study

Authors' conclusion

AVNA combined with HBP for noncontrolled atrial arrhythmia was feasible and clinically efficient.

Study context

Population
Patients with uncontrolled atrial arrhythmia undergoing atrioventricular nodal ablation (AVNA) after his-bundle pacing (HBP), 2017–2022
Participants
75 patients
Outcome
Feasibility and efficacy of AVNA combined with HBP
Methodological detailsmulticentre (3 hospitals)
  • Multicentre (3 hospitals)

Main finding

As reported in the abstract

AVNA result
GroupComplete atrioventricular (AV) blockSignificant AV nodal modulation (HR <60 bpm)AVNA failure
HBP + AVNA58 (77%)12 (16%)5 (7%)

HBP + AVNA

Complete atrioventricular (AV) block58 (77%)
Significant AV nodal modulation (HR <60 bpm)12 (16%)
AVNA failure5 (7%)

Observational data: associations, not effects.

Further findings

AVNA modulation/failure vs Complete AV block

OutcomeAVNA modulation/failureComplete AV blockP value
Atrial signal recorded by HBP lead, AVNA modulation/failure vs complete AV block11/175/58P < 0.001

Last follow-up vs Baseline

OutcomeBaselineLast follow-upP value
NYHA functional class, baseline vs last follow-up3.0 ± 0.71.6 ± 0.5P < 0.001
LVEF, baseline vs last follow-up47% ± 14%60% ± 9%P < 0.0001

Safety

Lead dislodgment during AVNA

No lead dislodgment occurred during the AVNA procedures

Acute His-bundle (HB) capture threshold increase >1 V

Patients with acute HB capture threshold increase >1 V
11 (15%)
Return to baseline value on day 1
9 patients

Original publication

His-bundle pacing and atrioventricular nodal ablation for noncontrolled atrial arrhythmia: A technical challenge with major clinical benefits. Heart Rhythm. Published 20 December 2022. doi:10.1016/j.hrthm.2022.12.022

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.